NVAX News Alert Novavax Inc (NVAX) 5.81 12/25/2014 15:12:56

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Novavax Inc (NVAX) 5.81 $NVAX

Cash Rich Novavax Has Upside Potential
Value Insight - at Seeking Alpha - Tue Dec 23, 12:44PM CST

NVAX: 5.81 (+0.18)

Novavax Shares Up 29.2% Since SmarTrend's Buy Recommendation (NVAX)
Comtex SmarTrend(R) - Tue Dec 23, 9:18AM CST
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 20th, 2014 at $4.54. In approximately 7 months, Novavax has returned 29.22% as of today's recent price of $5.86.
NVAX: 5.81 (+0.18)

Scanning Biotech Equities -- Celgene, Novavax, Amarin, Immunomedics, and Aeterna Zentaris
PR Newswire - Wed Dec 17, 7:40AM CST
Investor-Edge has initiated coverage on the following equities: Celgene Corporation (NASDAQ: CELG), Novavax Inc. (NASDAQ: NVAX), Amarin Corporation PLC (NASDAQ: AMRN), Immunomedics Inc. (NASDAQ: IMMU), and Aeterna Zentaris Inc. (NASDAQ: AEZS). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Tuesday, December 16, 2014, the NASDAQ Composite ended at 4,547.83, down 1.24%, the Dow Jones Industrial Average declined 0.65%, to finish the day at 17,068.87, and the S&P 500 closed at 1,972.74, down 0.85%. The losses were broad based as eight out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 776.88, down 1.27%, while the index has advanced 4.39% in the previous three months. Register for your complimentary reports on these five stocks at:
IMMU: 4.41 (+0.13), NVAX: 5.81 (+0.18), AMRN: 0.99 (unch), AEZS: 0.59 (-0.02), CELG: 109.60 (+3.48), CELGZ: 3.34 (-0.01)

Shares of NVAX Up 24.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Dec 15, 4:48PM CST
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 20th, 2014 at $4.54. In approximately 7 months, Novavax has returned 24.15% as of today's recent price of $5.63.
NVAX: 5.81 (+0.18)

Is Novavax Really Worth 25 Times As Much As Vical?
Intrepid Investor - at Seeking Alpha - Mon Dec 15, 11:08AM CST

VICL: 1.03 (+0.02), NVAX: 5.81 (+0.18)

Unveiled House Spending Bill Bullish For Ebola Stocks
Matthew Finston - at Seeking Alpha - Wed Dec 10, 8:46AM CST

NVAX: 5.81 (+0.18), NLNK: 39.08 (+1.36), OSUR: 10.26 (+0.25)

Novavax: Expect Chain Reaction In Stock Price From Multiple Catalytic Events
Michael Slattery - at Seeking Alpha - Wed Dec 10, 7:08AM CST

NVAX: 5.81 (+0.18)

Uptrend Call Working As Novavax Stock Rises 16.0% (NVAX)
Comtex SmarTrend(R) - Mon Dec 01, 9:55AM CST
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 20th, 2014 at $4.54. In approximately 7 months, Novavax has returned 15.99% as of today's recent price of $5.26.
NVAX: 5.81 (+0.18)

Novavax to Present at the 26th Annual Piper Jaffray Healthcare Conference
Thomson Reuters ONE - Wed Nov 26, 7:33AM CST
GAITHERSBURG, Md., Nov. 26, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that Stanley C. Erck, President and CEO, will present at the 26th Annual Piper Jaffray Healthcare Conference on Wednesday, December 3, 2014 at 11:00 a.m. ET in New York, NY at The New York Palace Hotel.
NVAX: 5.81 (+0.18)

InsiderInsights.com Daily Round Up 11/21/14: OPK, AVID, PAH, JCP
InsiderInsights - at Seeking Alpha - Mon Nov 24, 2:11PM CST

STFC: 23.53 (+0.43), EYES: 11.01 (+0.86), CMLP: 15.30 (+0.04), SEE: 43.40 (+0.42), DDD: 30.54 (-0.64), BBY: 38.89 (-0.80), MRD: 18.64 (-0.53), PAH: 23.00 (+0.01), RL: 184.35 (+0.70), AVID: 14.36 (+0.26), OPK: 9.63 (+0.21), LRE: 7.00 (-0.20), NVAX: 5.81 (+0.18), JCP: 6.50 (-0.24), AINC: 89.50 (+2.50), SYRG: 12.97 (-0.04), SFXE: 4.42 (+0.04)

Novavax Has Returned 13.1% Since SmarTrend Recommendation (NVAX)
Comtex SmarTrend(R) - Mon Nov 24, 10:15AM CST
SmarTrend identified an Uptrend for Novavax (NASDAQ:NVAX) on May 20th, 2014 at $4.54. In approximately 6 months, Novavax has returned 13.12% as of today's recent price of $5.13.
NVAX: 5.81 (+0.18)

Novavax Earnings In Retrospect: Down 0.6% in the Last 19 Days (NVAX)
Comtex SmarTrend(R) - Mon Nov 24, 9:43AM CST
Two weeks ago on November 5th, 2014 Novavax (NASDAQ:NVAX) reported earnings and analysts, on average, expected a loss of $0.07 on sales of $9.4 million. Novavax actually reported a loss of $0.08 per share on sales of $8.2 million, missing EPS estimates by $0.01 and missing revenue estimates by $1.2 million. Since the company's report, shares of Novavax have fallen from $5.13 to $5.10, representing a loss of 0.6% in the past 19 days.
NVAX: 5.81 (+0.18)

Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 21, 5:45PM CST
Novavax (NVAX) was granted fast track status in the U.S. for its experimental RSV F vaccine for the protection of infants via maternal immunization.
BIIB: 340.89 (+5.13), ANIP: 55.24 (+1.79), NVAX: 5.81 (+0.18), AMAG: 43.02 (+0.90)

Best Buy and Activision are big market movers
AP - Thu Nov 20, 3:27PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
SPLS: 17.82 (-0.01), VIPS: 19.95 (+0.41), CLV: 5.53 (-0.10), KIRK: 23.38 (+0.14), BBY: 38.89 (-0.80), CLF: 6.06 (-0.09), WSM: 75.32 (-0.61), CZR: 15.44 (+0.20), DISH: 72.63 (+0.54), ATVI: 20.35 (+0.12), NVAX: 5.81 (+0.18), TGT: 74.65 (-0.04), AGIO: 109.67 (+2.45), OPLK: 24.23 (-0.03), CRM: 60.33 (-0.17)

Novavax RSV vaccine candidate Fast Track'd
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 9:34AM CST

NVAX: 5.81 (+0.18)

U.S. FDA Grants Fast Track Designation to Novavax' RSV F-Protein Nanoparticle Vaccine for Protection of Infants Via Maternal Immunization
GlobeNewswire - Thu Nov 20, 9:12AM CST
Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Novavax' RSV F-Protein nanoparticle vaccine candidate (RSV F vaccine) for protection of infants via maternal immunization.
NVAX: 5.81 (+0.18)

InsiderInsights.com Daily Round Up 11/18/14: NES, TTS, RCAP, GSAT
InsiderInsights - at Seeking Alpha - Wed Nov 19, 3:29AM CST

CLUB: 5.90 (-0.07), MLM: 111.69 (-0.10), NES: 4.96 (-0.44), VOYA: 43.00 (+0.09), THG: 71.98 (+0.36), RXN: 28.18 (+0.06), GSAT: 2.97 (+0.03), LKFN: 42.45 (+0.31), PCLN: 1,149.78 (+2.17), TTS: 8.87 (+0.04), RCAP: 11.23 (+0.26), SPW: 86.64 (-0.11), NVAX: 5.81 (+0.18), WRLD: 79.98 (+0.15), TRUE: 23.50 (+0.31), BLMN: 23.79 (+0.18), BRX: 24.90 (-0.32), CMCSA: 58.07 (+0.17), SCHW: 30.67 (+0.01)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Geothermal AI Nodes Take Aim at Stranded Well Power

Updated Category News Views 48

Millions of idle wells are sitting under America like unwanted basement clutter, and GEIOS GEOFLEX thinks some can become small, self-contained AI power plants. That is the provocative idea behind its Dark Token Factory partnership with Aiden Digital Labs: bolt an autonomous compute module onto an abandoned or non-producing oil and gas well, pull geothermal heat from...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 150

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading
JOYY Q3 Growth Shows More Than Livestreaming Muscle

Updated Category News Views 59

Revenue finally has more than one pair of legs at JOYY, and that matters a whole lot more than a flashy quarterly headline. The company reported third-quarter 2026 revenue of US$624.6 million, up 15.6% from a year earlier and 5.7% from the prior quarter. Those are not microscopic moves, and the composition is the part that deserves the hard stare. JOYY is still rooted in...

Continue Reading
COSCO Shipping Uses CIIE to Put People in the Chain

Updated Category News Views 57

A Supply Chain Is Not Just Steel and Schedules Containers do not shake hands, but the people routing them certainly do. That was the useful, rather human point underneath COSCO SHIPPING's presence at the ninth China International Import Expo in Shanghai: global logistics is a physical business built on relationships that have to survive different languages, markets,...

Continue Reading
IDEMIA Lands Sweden's Critical 5G Connectivity Job

Updated Category News Views 43

A hospital monitor going dark because a device was misprovisioned is not the kind of connectivity hiccup anybody gets to shrug off. That is why IDEMIA Secure Transactions winning the Region Västra Götaland assignment deserves more attention than the usual telecom plumbing announcement. The region is building what it calls Sweden's largest private 5G network, and the job...

Continue Reading
Arbor Realty's Loan Mess Meets a Dividend Shutdown

Updated Category News Views 89

A dividend suspension lands differently when the loan book is already coughing up smoke. Arbor Realty Trust’s latest disclosed numbers are not the sort that investors can shrug off as one ugly quarter and forget by Friday. The company reported a third-quarter 2026 GAAP net loss of $85.4 million, suspended its quarterly cash dividend effective immediately, and described...

Continue Reading
Swell Partners' Awards Highlight Culture, Not Metrics

Updated Category News Views 41

Recognition Lands in a Crowded Talent Market Two shiny Stevie trophies do not pay payroll, but they can say something useful about a company trying to stand out in the noisy talent-services business. Swell Partners has been named 2026 Company of the Year in Business Services and has seen founder and CEO Cari Gatto receive Best Female CEO of the Year. For a private firm...

Continue Reading
Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 77

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
Automotive Laminates: Small Market, Real EV Leverage

Updated Category News Views 126

Cabin trim has become a surprisingly serious battleground, and that is the whole point of this automotive laminates story. Nobody buys a vehicle because somebody bragged about a multilayer film behind the door panel. Yet the materials under the fingertips, beneath the carpet, and around the dashboard increasingly decide whether an interior feels cheap, quiet, durable, or...

Continue Reading
Honda Prelude’s Hybrid Return Tests a Narrow Niche

Updated Category News Views 0

A low-slung coupe showing up in Newfoundland is not exactly a volume-sales thunderclap, and that is precisely why the 2027 Honda Prelude deserves a closer look. Steele Honda in St. John’s is presenting the hybrid two-door as a fresh choice for buyers who want something livelier than the usual practical commuter. For Honda, and for investors watching Honda Motor Co....

Continue Reading

Top 5 Most Recently Viewed Articles

Safety Socket LLC Wins Major Court Ruling Against Counterfeiters

Updated Category News Views 692

Safety Socket LLC Achieves Legal Victory Against Counterfeit Suppliers The jury in a federal court trial has ruled in favor of Safety Socket LLC, confirming that certain fasteners intended for military applications were counterfeit. This significant case, known as Safety Socket LLC v. Relli Technology, Inc., was adjudicated in the U.S. District Court for the Northern...

Continue Reading
Innovative Energy Project Completion in the Gulf of Mexico

Updated Category News Views 244

Completion of McDermott's EPCIC Project in Gulf of Mexico Recently, McDermott celebrated the successful conclusion of its engineering, procurement, construction, installation, and commissioning (EPCIC) project for Shell Offshore Inc., a subsidiary of Shell plc. This project, executed in the Gulf of Mexico, is pivotal in starting oil production at the Whale development....

Continue Reading
Hyperscale Data Plans Major Expansion for AI Infrastructure

Updated Category News Views 365

Significant Power Capacity Increase for Hyperscale Data Hyperscale Data, Inc. (AMEX: GPUS) has recently reported a promising advancement as its subsidiary, Alliance Cloud Services (ACS), has reached a preliminary agreement aimed at boosting the power capacity at its data center. This enhancement, intended to promote growth in artificial intelligence (AI) infrastructure,...

Continue Reading
Global Sewage Crisis Costs $4 Trillion Annually

Updated Category News Views 17

The Overlooked Menace of Sewage Pollution Folks, let me hit you with a harsh reality: while everyone’s chatting about plastic in the ocean or overfishing, there’s a silent disaster slipping under the radar. We’re talking sewage pollution—an issue so vast it's draining the global economy to the tune of $4 trillion each year. That’s what they’re yammering about...

Continue Reading
Inspire Medical Systems, Inc. Class Action Lawsuit Update

Updated Category News Views 231

Inspire Medical Systems, Inc. Investors Take Note The financial landscape for investors is anything but static, particularly for those involved with Inspire Medical Systems, Inc. This article serves as a reminder for investors about the ongoing class action lawsuit, including the critical lead plaintiff deadline. Investors should remain vigilant and informed regarding...

Continue Reading